Monday, June 16, 2008

Digitek Injuries






Digitek, a medication indicated for patients with heart failure and abnormal heart rhythms, was recently recalled by its manufacturer Actavis Totowa LLC. The recall is a Class One FDA nationwide recall of Digitek® (digoxin tablets, USP, all strengths) for oral use. A Class One recall is the most serious level of recalls.

The "all lot" recall is due to the serious potential that the pills were manufactured with double the approved thickness, which may contain twice the approved level of active ingredient. As a result, the drug, in its defective form, is recognized to pose a risk of digitalis toxicity in patients. Reports of hypotension, cardiac instability, bradycardia, and death have been reported.

For more informaton, see the following:
  1. FDA Notice

  2. Activis Consumer Question/ Answer:
  3. Web MD:

    The Lyon Firm is investigating these cases on a local and national basis.

Bush Supports New ADA Requirements

The Bush Administration in an effort to address the needs of the many disabled veterans returning from Iraq is supporting additional changes to the American's with Disabilities Act, a bipartisan piece of legislation that requires businesses to make accommodations for disabled consumers. See today's New York Times Article for additional details:

The support conflicts with the Bush Administration's efforts to limit consumer's rights to challenge big companies when they have been injured by a defective product. Moreover, it is a tacit admission that the numbers of veterans affected by the Iraq war justifies such broad economic measures to assist those soldiers in their return to civilian life.

The U.S. Chamber of Commerce opposes such changes.